We estimated associations of subjective cognitive decline (SCD) with neuro-imaging markers of dementia and cognitive functioning in patients with a history of vascular disease without objective cognitive impairment. Within the SMART-Medea study, 599 patients (62±9 years) had 1.5T brain MRI and cognitive testing at baseline and after 8 years of follow-up. Using multiple regression analyses, we estimated cross-sectional and longitudinal associations of SCD according to research criteria with volumes of total brain, hippocampus, white matter hyperintensities (WMH), and presence of lacunes; and with memory, executive functioning, information processing speed, and working memory. SCD was associated with increased risk of lacunes at baseline (RR=1.48, 95% CI: 1.03; 2.12), but not during follow-up. No significant associations with volumes of WMH, total brain or hippocampus were observed. SCD was crosssectional associated with poorer executive functioning and speed, but not during follow-up.
Introduction
Subjective cognitive decline (SCD) is common among older individuals (Burmester et al., 2016) .
Although SCD is often not indicative of underlying disease, it is also realized that those who express complaints of SCD are at increased risk of cognitive impairment and dementia (Burmester et al., 2016; Mendonça et al., 2015; Mitchell et al., 2014; Neto and Nitrini, 2016; Rabin et al., 2017) . As such, SCD has been conceptualized as the earliest symptomatic prodromal state, or pre-mild cognitive impairment (pre-MCI) stage, of Alzheimer's disease (AD) (Jessen, 2014) . Consequently, SCD is increasingly the focus of scientific research and evidence exists that some patients with SCD may show early signs of brain changes related to MCI and AD (Garcia-Ptacek et al., 2014) .
Most studies that investigated the etiology of SCD by examining brain MRI correlates, investigated hippocampal volume and white matter hyperintensities (WMH). These studies mainly found a decrease in hippocampal volume (Cherbuin et al., 2015; Hafkemeijer et al., 2013; Perrotin et al., 2015; Stewart et al., 2011 Stewart et al., , 2008 Striepens et al., 2010; Wiesje M van der Flier et al., 2004) and an increase in WMH volume (de Groot et al., 2001; Minett, 2005; Stewart et al., 2008) .
These previous studies were mainly conducted in patients visiting memory clinics (Hafkemeijer et al., 2013; Minett, 2005; Perrotin et al., 2015; Striepens et al., 2010; Wiesje M van der Flier et al., 2004 ) and in community-based populations (Cherbuin et al., 2015; de Groot et al., 2001; Stewart et al., 2011 Stewart et al., , 2008 . It is likely that the factors associated with SCD depend on the setting in which it is examined. SCD in young adults, for example, likely has a different etiology (and prognosis) than in older persons attending a memory clinic. Furthermore, most studies focused on memory M A N U S C R I P T
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Patients with vascular disease are at increased risk of cognitive decline and dementia (Kalaria et al., 2008; Mayeux and Stern, 2012; Reitz and Mayeux, 2014) . Brain MRI markers of cerebral small vessel disease (cSVD), including WMH and lacunes of presumed vascular origin (lacunes), are also common in these patients (Geerlings et al., 2010) . Yet, few studies have assessed the occurrence of SCD and associated abnormalities on brain MRI in these patients (Haley et al., 2009; Uiterwijk et al., 2014) . Also, it is unclear if SCD is associated with increased risk of brain volume changes and cognitive decline over time in patients with vascular disease, as to our knowledge only one study researched SCD and this association in patients with vascular disease (Haley et al., 2009 ).
We aimed to examine whether SCD is associated with brain changes, particularly an increased WMH volume, presence of lacunes, decreased total brain volume, and decreased hippocampal volume, in a cohort of patients with a history of vascular disease without objective cognitive impairment. Furthermore, we aimed to examine if these patients with vascular disease and SCD showed more brain volume changes and cognitive decline over time than those without SCD. We hypothesized that SCD in this population would primarily be associated with vascular brain lesions rather than with loss of brain or hippocampal volume. We also hypothesized that SCD was associated with greater cognitive decline over time, in particular executive functioning and information processing speed, and that presence of cSVD markers became more apparent over time.
Methods

Study design
The Second Manifestations of ARTerial disease-Memory, depression and aging (SMART-Medea) study is an ongoing prospective cohort study aimed to investigate brain changes on MRI, latelife depression and cognitive decline in patients with a history of vascular disease (Grool et al., 2011) . The SMART-Medea study started in 2006 as an ancillary study to the SMART-MR study, of which rationale and design have been described previously (Geerlings et al., 2010 follow-up measurements for the SMART-MR cohort, and measurements were then added as part of the SMART-Medea study, including depression assessment, psychosocial risk factor questionnaires, saliva sampling for stress hormones, and a 3-dimensional T1-weighted MR image to assess hippocampal volumes. During a one day visit to the hospital, patients underwent a physical examination, ultrasonography of the carotid arteries, sampling of blood and urine, neuropsychological and depression assessment, and a 1.5 tesla brain MRI scan.
Questionnaires were used for assessing demographics, risk factors and medical history, medication use, functioning, psychosocial vulnerability and stress factors, and depressive symptoms. From 2013 through 2017 a second follow-up (after a mean of 8 years) was performed in 329 participants including brain MRI and cognitive testing.
The SMART-MR and SMART-Medea study were approved by the ethics committee and written informed consent was obtained from all patients.
Subjective cognitive decline
Subjective cognitive decline was assessed using self-report questions in line with the suggestions of the Subjective Cognitive Decline-Initiative (SCD-I) working group . They included questions on the memory domain as well as concentration . The following questions were asked 1) 'Do you think your memory is worse than others of your age?', 2) 'Do you think your memory deteriorated compared to 5-10 years ago?', 3) 'Do you think your attention/concentration is worse than others of your age?' and 4) 'Do you think your attention/concentration deteriorated compared to 5-10 years ago?'. Scores were on a 5-point Likert scale. We defined patients as having subjective cognitive decline if they scored 'a bit worse' or 'a lot worse' on both memory questions or on both concentration questions.
Cognitive functioning
Objective cognitive functioning was assessed with a set of standard neuropsychological tests covering the domains memory, working memory, executive functioning and information processing speed. Memory functioning was assessed with the 15 Word Learning Test (15-WLT) (immediate recall based on 5 trials and delayed recall) (Brand and Jolles, 1985) and with the delayed recall of the Rey-Osterrieth Complex Figure test (Osterrieth, 1944) . Working memory was assessed with the longest span scores of the Forward Digit Span and Backward Digit Span (Wechsler, 2008) .Executive functioning was assessed by the Visual Elevator test (Robertson et al., 1996) (10 trials), the Brixton Spatial Anticipation test (Burgess and Shallice, 1996) and Verbal Fluency tests (letter 'A' with a time span of 60 seconds and category 'animal' with a time M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 8 span of 120 seconds) (Wilkins et al., 1987) . Information processing speed was assessed by the Digital Symbol Substitution Test (Lezak et al., 2004) Elevator test and then multiplied by minus 1, so that higher scores represented better performance. The Brixton Spatial Anticipation test scores were also multiplied by minus 1 so that higher scores represented better performance. At follow-up composite z-scores of the cognitive domains were calculated by subtracting the respective mean test score at baseline from the individual test score at follow-up divided by the standard deviation of the baseline test score of the study sample with follow-up cognitive scores available.
At baseline, objective cognitive impairment was defined as a score of 1.5 standard deviation below age, sex, and education adjusted z scores (composed from the cohort itself) of one or more cognitive domains. As we were interested in pre-MCI subjective cognitive decline,
i.e. cognitive complaints without objective cognitive impairment on formal cognitive testing we excluded persons with objective cognitive impairment (26%) from the study sample.
Magnetic resonance imaging protocol
At baseline and follow-up, the MR images were obtained using a 1.5 tesla whole-body system Knoops et al., 2010) . For hippocampus volumes, a T1-weighted 3D fast-field-echo sequences was acquired (TR/TE: 7.0/3.2 ms; flip angle, 8°; field of view 240 mm; matrix size, 240 × 256; slice thickness 1.0 mm; no gap; 170 slices) (Knoops et al., 2009 ).
Lacunes and other infarcts
Two trained investigators and a senior neuroradiologist visually inspected the whole brain for presence of lacunes and other infarcts, blinded to patient history and diagnosis. Rating discrepancies were re-evaluated in a consensus meeting. Lacunes were defined as cavitated lesions of 3-15 mm in diameter and located in the subcortical white matter, thalamus, or basal M A N U S C R I P T
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10 ganglia, according to STRIVE criteria (Wardlaw et al., 2013) . Hyperintensities located in the white matter also had to be hypointense on T1-weighted and FLAIR images in order to distinguish them from WML. Dilated perivascular spaces were distinguished from lacunes based on their location (along perforating or medullary arteries, often symmetric bilaterally, usually in the lower third of the basal ganglia or in the centrum semiovale), shape (round/oval), and the absence of gliosis (Kloppenborg et al., 2012) . We did not assess recent small subcortical infarcts, because we did not include a diffusion-weighted imaging (DWI) sequence in the MRI protocol.
Brain segmentation
The T1-weighted gradient-echo, IR sequence, and FLAIR sequence were used for brain segmentation according to the k-nearest neighbor (kNN) classification, as has been described elsewhere (Anbeek et al., 2005 (Anbeek et al., , 2004 . It distinguishes gray matter, white matter, sulcal and ventricular cerebrospinal fluid, and brain lesions (WMH, lacunes and other infarcts). All segmentations were visually checked by an investigator to check if lacunes and other infarcts were correctly segmented, and adjusted if necessary. Additionally, all WMH segmentations were visually checked by an investigator using an image processing framework (MeVisLab 2.7.1., MeVis Medical Solutions AG, Bremen, Germany) to ensure that brain infarcts (including lacunes) were correctly removed from the WMH segmentations. Incorrectly segmented voxels were added to the correct segmentation volumes using the image processing framework. Total brain volume was calculated by summing the volumes of gray and white matter and, if present, the volumes of WMH, lacunes and other infarcts. All volumes superior to the foramen magnum were M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 11 included. As a result, the total brain volume included the cerebrum, brainstem, and cerebellum.
Total intracranial volume (ICV) was calculated by summing up total brain and CSF volumes.
Manual segmentation of hippocampal volumes has been described in detail elsewhere (Knoops et al., 2012) . Briefly, the sagittal T1-weighted images were tilted to the coronal plane and orientated perpendicular to the long axis of the left hippocampus. The hippocampus was manually outlined by two trained investigators, blinded to all clinical information, on an average of 40 slices and included the hippocampus proper, subiculum, fimbria, alveus, and dentate gyrus.
For the present study, segmentations of total brain volume, CSF, WMH volume, and lacunes were available at baseline and follow-up. Manual segmentations of hippocampal volume were available for the baseline, but not for the follow-up.
Other variables
Age, sex, and highest level of education were assessed with questionnaires. Education was recalculated into 3 categories from the Dutch educational system which ranged from no education/primary school to University education. Low level of education included no education or primary school only (comparable to up to 6 years of education), high level education included higher professional education and (pre-)university education (comparable to ≥15 years of education), and all other educational levels were defined as an intermediate level of education (comparable to around 7-14 years of education).
Depressive symptoms were assessed with the Patient Health Questionnaire (PHQ-9) (Kroenke et al., 2001) . The PHQ-9 assesses the presence of 9 symptoms for major depression 
Study sample
Of the 754 patients of the SMART-Medea study, 121 patients had cognitive impairment and 32 had missing data on cognitive impairment, and these 153 persons were excluded from the current study sample. Of the remaining 601 persons 2 persons did not have data on subjective decline available, leaving 599 persons with SCD data and cognition data. Of these 599 persons, lacunes. Follow-up data on hippocampal volume was not available for this study.
Data analysis
First, baseline characteristics were calculated for the participants with and without SCD. Next, we used linear regression analysis to estimate the associations between SCD and volume of WMH, total brain volume and hippocampal volume, respectively. WMH volume was naturally logtransformed because of non-normal distribution, and after analyses transformed back to mL via exponentiation. We used a modified Poisson-regression with log-link function and robust standard errors to estimate the relative risks (RR) of SCD with presence of lacunes. We estimated RR as these are recommended instead of odds ratio's when an outcome is frequent (>10%) to prevent overestimation of the true risk (Knol et al., 2012 
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14 and adjustments were made for the corresponding baseline MRI marker. Other covariates were the same as model 1 and 2 from the cross-sectional analyses.
Similarly, we used linear regression analysis and ANCOVA to estimate the cross-sectional and prospective associations between SCD and cognitive performance per cognitive domain. In model 1, we adjusted the analysis for age, sex, educational level and depressive symptoms, and for the prospective analysis with follow-up, where cognitive performance was the dependent variable, we also adjusted for the baseline z-score of the corresponding cognitive domain. In model 2 we additionally adjusted for cardiovascular risk factors.
Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 25.0. Table 1 shows the baseline characteristics of the study sample for participants with and without SCD. Of the 599 participants, 143 (23.9 %) had SCD. Participants without SCD were on average older (62 (SD 9) years of age) than those with SCD (60 (SD 9) years of age). Results of neuropsychological tests and depression questionnaires for participants with and without SCD are presented in Supplementary Table 1 . The score on the Mini-Mental State Examination was 28.8 (SD 1.2) for participants without SCD and 28.7 (SD 1.4) for participants with SCD. Of the participants without SCD 10% had a score of 6 or higher on the PHQ-9, and of the participants with SCD, this was 31%. Table 4 and Figure 1 present the cross-sectional associations between SCD and performance on the cognitive domains. Compared to patients without SCD, those with SCD performed worse on executive functioning (B= -0.27; 95% CI: -0.44; -0.11, p=0.001, model 1) and speed (B= -0.18; 95% CI: -032; -0.03, p=0.020, model 1), and also on memory, but this did not reach statistical significance. No association with working memory was observed. Table 5 and Figure 2 show the results of the longitudinal associations between SCD and cognitive performance. Although all patients declined in their cognitive performance (Figure 2 ), no significant differences were observed between patients with and without SCD, except for information processing speed where patient with SCD showed less decline compared to patients without SCD (Table 5) .
Results
Discussion
In this study among patients with a history of vascular disease without objective cognitive impairment, subjective cognitive decline (SCD) was associated with an increased risk of lacunes, independent of age, sex, education, depressive symptoms, and cardiovascular risk factors. SCD M A N U S C R I P T
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17 was also associated with smaller total brain volume and larger volume of white matter hyperintensities (WMH), although this relationship did not reach statistical significance. No association with hippocampal volume was observed. Furthermore, SCD was associated with poorer executive functioning and information processing speed, but not with memory or working memory. During on average 8 years of follow-up, SCD was not associated with a decrease in total brain volume, or an increase in WMH volume or lacunes. Also, SCD was not associated with a decline in cognitive performance.
To our knowledge, no other study examined the association between SCD and presence of lacunes. The question is if presence of lacunes by itself relates to SCD, or whether the notion of having experienced a stroke -which also relates to lacune presence -is a key determinant of SCD. In our analyses, the relationship between SCD and lacunes was partly explained by a history of stroke. It is possible that co-occurring large vessel disease, if the participant was aware of this, led to complaints of cognitive decline.
We found that SCD was associated with a larger WMH volume, although this relationship did not reach statistical significance. During follow-up, SCD was not associated with an increase in WMH volume. Results from previous studies that examined the association between SCD and WMH in different populations were inconsistent. In community-dwelling older adults, one study found no association between SCD and severity of WMH (Bartley et al., 2012) , while others found more severe WMH to be associated with SCD (de Groot et al., 2001; Stewart et al., 2011 Stewart et al., , 2008 .
One of these studies also found an association between an increase in WMH and presence of SCD after 4 years of follow-up (Stewart et al., 2011) . A study in patients with hypertension did not find an association between SCD and WMH (Uiterwijk et al., 2014) , while another study in M A N U S C R I P T
18 patients with cardiovascular disease did find SCD to be associated with an increase in WMH (Haley et al., 2009 ). In memory-clinic patients, one study found that the severity of WMH was associated with SCD (Minett, 2005) .
In our study within patients with vascular disease, SCD was associated with slightly smaller total brain volume, but this did not reach statistical significance. No association with hippocampal volume was observed. Previous cross-sectional studies that were conducted in patients from a memory clinic, also found no significant associations between SCD and global brain volume (Striepens et al., 2010) or between SCD and total gray matter volume (Scheef et al., 2012) . Studies examining the association between SCD and hippocampal volume found various results across different settings. Some studies observed smaller hippocampal volumes in persons with SCD in memory clinics (Hafkemeijer et al., 2013; Perrotin et al., 2015; Wiesje M van der Flier et al., 2004) , while others did not (Hong et al., 2015; Ryu et al., 2017; Tepest et al., 2008) .
In community-dwelling older adults, one study found an association between SCD and a smaller hippocampal volume (Cantero et al., 2016) , and others found that people with a smaller hippocampal volume more often had SCD (Stewart et al., 2011 . One of the latter studies was a longitudinal study and also reported an association between loss of total gray matter volume and an increase in reported SCD at follow-up (Stewart et al., 2011) , which is in contrast with our study as we did not find an association between SCD and a decrease in brain volume over time. Another longitudinal study found an association between smaller hippocampal volume and SCD only at follow-up but not at baseline (Cherbuin et al., 2015) . It is possible that loss of brain or hippocampal volume contributes to SCD, while having SCD is not per se M A N U S C R I P T
19 associated with a smaller brain or hippocampal volume, as is the case in our population of patients with a history of vascular disease.
In this study, we found that presence of SCD was associated with poorer performance on executive functioning and information processing speed, and with memory, although the latter did not reach statistical significance. It should be noted that we excluded patients with objective cognitive impairment based on age, sex, and education adjusted z-scores of one or more cognitive domains. Still, differences -particularly in the executive functioning and speed domain -could be observed between patients with and without SCD. During follow-up, however, we did not find statistically significantly decreases in cognitive performance associated with SCD.
Unexpectedly, we observed a smaller decline in speed in patients with SCD compared to those without, a finding for which we do not have a clear explanation. Also, previous studies mainly focused on the associations between SCD and objective cognitive performance (Burmester, Mitchell) or on progression of SCD complaints to MCI and dementia (Mendonça et al., 2015; Mitchell et al., 2014; Neto and Nitrini, 2016; Rabin et al., 2017) , and our findings are therefore difficult to compare. Also, previous studies did not exclude patients with objective cognitive impairment at baseline which make these studies and our study not fully comparable.
A strength of this study is that we examined different neuro-imaging markers, including neurodegenerative and cSVD markers in contrast to many previous studies that examined one or two markers, and that we examined objective performance across different cognitive domains. Also, SCD was defined according to recently proposed research criteria, such as the inclusion of other cognitive domains apart from memory . Previous studies used various methods of reporting cognitive complaints, mainly focusing on memory M A N U S C R I P T
20 complaints, which limits comparability. In addition, we were able to examine brain MRI markers and cognitive functioning at baseline as well as after 8 years of follow-up. Finally, we adjusted our analyses for cardiovascular risk factors and depressive symptoms. Adjustment for depressive symptoms is lacking in some other studies (Cantero et al., 2016; Hafkemeijer et al., 2013; Hong et al., 2015; Perrotin et al., 2015; Rogne et al., 2016; Ryu et al., 2017; W M van der Flier et al., 2004) .
A limitation of this study is the relatively large number of patients who were lost to follow-up, either because they died or because they were unwilling or unable to participate. As a result, power to detect associations was reduced, and more importantly, the most resilient and healthy patients likely participated at follow-up. Yet, patients with and without SCD at baseline were fairly similarly likely to be lost to follow-up (59% lost to follow-up in patients with versus 53% without SCD). Another limitation is that we did not have hippocampal volume available at follow-up. A last limitation could be that we did not assess recent small subcortical infarctions.
However, this should not impact the assessment of lacunes, since lacunes are cavitated by definition whereas recent small subcortical infarctions are not. Hypothetically, recent subcortical infarctions could be misclassified as WMH.
In conclusion, in this cohort of patients with a history of vascular disease without objective cognitive impairment, SCD was associated with an increased risk of lacunes, and with poorer executive functioning and information processing speed at baseline, but not during 8 years of follow-up. More prospective studies are needed to further elucidate the relationship between subjective cognitive decline, brain imaging markers, and cognitive decline and the role of SCD in the preclinical stage of Alzheimer's disease. 3. The manuscript has not been published before and is not being considered for publication in another journal.
4. The studies were approved by the ethics committee and written informed consent was obtained from all patients.
5. All authors have reviewed the manuscript and approved of its content.
